PUBLISHER: The Business Research Company | PRODUCT CODE: 2127357
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127357
Intraoperative radiotherapy devices are advanced medical systems designed to deliver a targeted dose of radiation directly to the treatment site during surgery immediately after the removal of diseased tissue. This technique helps eliminate remaining cancer cells while reducing radiation exposure to surrounding healthy tissues. Intraoperative radiotherapy devices integrate sophisticated radiation delivery and imaging technologies to ensure accurate, efficient, and precise treatment within the operating room.
The primary product categories of intraoperative radiotherapy (IORT) devices include mobile intraoperative radiotherapy systems and fixed intraoperative radiotherapy systems. Mobile intraoperative radiotherapy systems are portable radiation delivery platforms that can be transported between operating rooms, allowing targeted radiation therapy to be administered immediately after tumor removal during surgical procedures. These systems employ technologies such as electron beam intraoperative radiotherapy, low-energy X-ray intraoperative radiotherapy, high-energy X-ray intraoperative radiotherapy, and intraoperative brachytherapy. They are used in the treatment of breast cancer, colorectal cancer, pancreatic cancer, prostate cancer, head and neck cancer, and other conditions, serving hospitals, ambulatory surgical centers, cancer research institutes, and specialty oncology clinics.
Tariffs are influencing the intraoperative radiotherapy (IORT) devices market by increasing the cost of imported radiation systems, imaging components, precision electronics, and specialized medical equipment required for operating room-based cancer treatments. The effects are more significant across mobile and fixed intraoperative radiotherapy systems, electron beam systems, and X-ray-based technologies because of their dependence on globally sourced components, particularly in North America, Europe, and Asia-Pacific. Higher equipment costs may influence hospital procurement decisions and technology modernization efforts while also encouraging manufacturers to establish local production, diversify supply chains, and develop cost-effective radiotherapy solutions.
The intraoperative radiotherapy (iort) devices market research report is one of a series of new reports from The Business Research Company that provides intraoperative radiotherapy (iort) devices market statistics, including intraoperative radiotherapy (iort) devices industry global market size, regional shares, competitors with a intraoperative radiotherapy (iort) devices market share, detailed intraoperative radiotherapy (iort) devices market segments, market trends and opportunities, and any further data you may need to thrive in the intraoperative radiotherapy (iort) devices industry. This intraoperative radiotherapy (iort) devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intraoperative radiotherapy (IORT) devices market size has grown strongly in recent years. It will grow from $0.46 billion in 2025 to $0.5 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing cancer incidence rates, rising adoption of advanced cancer treatment procedures, growing demand for targeted radiation therapies, expansion of oncology care infrastructure, increasing clinical adoption of intraoperative treatment approaches.
The intraoperative radiotherapy (IORT) devices market size is expected to see strong growth in the next few years. It will grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing preference for personalized cancer treatment, rising demand for precision radiation delivery solutions, growing adoption of mobile intraoperative radiotherapy systems, expanding integration of image-guided surgical technologies, increasing investment in advanced oncology treatment facilities. Major trends in the forecast period include increasing adoption of precise radiation delivery systems, growing integration of real-time imaging in surgical procedures, rising demand for single-session cancer treatment approaches, expansion of minimally invasive oncology treatment solutions, growing development of compact and mobile radiotherapy systems.
The rising incidence of breast cancer is expected to drive the growth of the intraoperative radiotherapy (IORT) devices market going forward. Breast cancer refers to a condition in which abnormal cells in breast tissue grow uncontrollably, forming malignant tumors that may spread to other areas of the body. The increasing incidence of breast cancer is creating demand for timely diagnosis and effective treatment approaches, accelerating the adoption of advanced therapies that enhance clinical outcomes and improve disease management. The growing number of breast cancer cases is increasing the number of patients undergoing breast-conserving surgery, thereby driving demand for intraoperative radiotherapy (IORT) devices that provide targeted radiation delivery during surgery and reduce the requirement for multiple postoperative radiotherapy sessions. For instance, in June 2026, according to the Centers for Disease Control and Prevention, a US-based federal agency, the United States reported 288,494 new cases of female breast cancer in 2023, while 43,402 women died from the disease in 2024. Therefore, the rising incidence of breast cancer is driving the growth of the intraoperative radiotherapy (IORT) devices market.
Key companies operating in the intraoperative radiotherapy (IORT) devices market are concentrating on developing advanced robotic-assisted radiation therapy platforms to improve treatment precision, streamline clinical workflows, and enhance connectivity across surgical oncology procedures. Robotic-assisted intraoperative radiotherapy platforms are advanced systems that enable highly precise radiation delivery during surgery through automated positioning, digital treatment planning, and seamless integration with hospital infrastructure. For example, in April 2025, Carl Zeiss Meditec AG, a Germany-based medical technology company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ZEISS INTRABEAM 700, a next-generation intraoperative radiotherapy platform. The system features robotic-assisted precision, digital-first workflow architecture, integrated Radio Frequency Identification (RFID)-enabled applicator recognition, and advanced treatment planning software, supporting more accurate and efficient intraoperative radiation therapy for neuro-oncology and breast cancer procedures.
In October 2023, Elekta AB, a Sweden-based company offering radiation therapy, radiosurgery, and brachytherapy systems along with treatment planning software for cancer and neurological disorder care, acquired the Xoft brachytherapy business from iCAD Inc. for an undisclosed value. Through this acquisition, Elekta aimed to expand its intraoperative and electronic brachytherapy offerings while increasing access to advanced radiation treatment solutions across various healthcare settings by utilizing its worldwide commercial infrastructure. iCAD Inc. is a US-based medical technology company that developed the Xoft Axxent Electronic Brachytherapy (eBx) System, an electronic radiation technology platform commonly used for intraoperative radiotherapy (IORT) applications.
Major companies operating in the intraoperative radiotherapy (iort) devices market report are Carl Zeiss Meditec AG, Elekta AB, Siemens Healthineers AG, Panacea Medical Technologies Pvt. Ltd., Brainlab AG, Ion Beam Applications SA, IntraOp Medical Corporation, S.I.T. Sordina IORT Technologies S.p.A., Xstrahl Ltd, Eckert & Ziegler BEBIG GmbH, RaySearch Laboratories AB, PTW Freiburg GmbH, ORFIT Industries NV, Cablon Medical B.V., Standard Imaging Inc., LAP GmbH Laser Applications, Mirion Technologies Inc., GMV Innovating Solutions SL, CivaTech Oncology Inc., Radiation Products Design Inc.
North America was the dominant region in the intraoperative radiotherapy (IORT) devices market in 2025. Western Europe is expected to be the rapidly growing region in the forecast period. The regions covered in the intraoperative radiotherapy (IORT) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intraoperative radiotherapy (IORT) devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The intraoperative radiotherapy devices market consists of revenues earned by entities by providing services such as remote monitoring services, equipment lifecycle management services, and decommissioning and disposal services. The market value includes the value of related goods sold by the service provider or included within the service offering. The intraoperative radiotherapy devices market also includes sales of laser positioning devices, radiation monitoring badges, and equipment transport trolleys. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intraoperative Radiotherapy (IORT) Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intraoperative radiotherapy (iort) devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intraoperative radiotherapy (iort) devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intraoperative radiotherapy (iort) devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.